Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie Capital Limited. MedSci Healthcare operates one of the largest online professional...
MedSci Healthcare Holdings Limited’s Mainboard Listing on the Hong Kong Stock Exchange
QuantaSing’s $40 Million IPO
Wilson Sonsini represented QuantaSing, while Latham & Watkins advised the joint bookrunners on the offering. QuantaSing Group Limited announced the pricing of its initial public offering...
Fenbi’s HK$198 Million Listing on The HKSE
Cooley advised the underwriters involved in the listing while Wilson Sonsini Goodrich & Rosati represented Fenbi. Fenbi, an internet-born test preparation company, proposed the listing of...
OrbusNeich Medical Group’s Initial Public Offering
Baker McKenzie advised the underwriters on the deal. OrbusNeich Medical Group executed an initial public offering. OrbusNeich Medical is a major global medical device manufacturer specializing...
OrbusNeich Medical Group’s US$61.6 Million Initial Public Offering
Baker McKenzie advised the underwriters on the deal while O’Melveny represented OrbusNeich Medical Group. OrbusNeich Medical Group Holdings Limited (6929.HK) announced its approximate US$61.6 million (approximately HK$481...
Shanghai Chicmax Cosmetic Co., Ltd.’s US$141.5 Million Initial Public Offering on the HKSE
Clifford Chance and JunHe advised cosmetics company Shanghai Chicmax Cosmetic Co., Ltd. on the deal. Freshfields Bruckhaus Deringer advised the joint sponsors. Shanghai Chicmax Cosmetic Co.,...
Weilong’s US$130.3 Million Global Offering and Hong Kong Listing
Paul Hastings advised Morgan Stanley Asia Limited, China International Capital Corporation Hong Kong Securities Limited and UBS Securities Hong Kong Limited. Weilong Delicious Global Holdings Ltd....
Atour Lifestyle’s $52 Million Initial Public Offering
Davis Polk, Maples and Calder and JunHe LLP advised Atour, while Latham & Watkins and Zhong Lun Law Firm advised the underwriters on the transaction. Atour...
Giant Biogene Holding Co., Ltd’s Listing on the Hong Kong Stock Exchange
Freshfields Bruckhaus Deringer advised Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited, the joint sponsors and the underwriters. Maples and Calder,...
Dingdang Health Technology’s IPO
Paul Hastings advised the joint sponsors and the joint global coordinators on the deal. Maples and Calder and Clifford Chance counsel to Dingdang Health Technology Group...
Shenzhen EVOC Intelligence Technology Company Limited’s Privatization of EVOC Intelligent Technology Company Limited
Kirkland & Ellis advised China International Capital Corporation Hong Kong Securities Limited, as financial adviser to Shenzhen EVOC Intelligence Technology Company Limited. Shenzhen EVOC Intelligence Technology...
Bank of East Asia’s US$250 Million Inaugural Non-Preferred Loss Absorbing Capacity Notes
Linklaters advised a consortium of multinational investment banks. The transaction concerned US$250m non-preferred loss absorbing capacity (LAC) bond under the US$6bn medium term note programme by The...